Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,363 | 446 | 96.0% |
| Education | $189.27 | 9 | 2.5% |
| Consulting Fee | $113.96 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,023 | 57 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $759.00 | 47 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $730.64 | 31 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $510.35 | 24 | $0 (2024) |
| Amgen Inc. | $462.16 | 24 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $444.79 | 30 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $326.65 | 34 | $0 (2021) |
| Fresenius USA Marketing, Inc. | $304.56 | 20 | $0 (2024) |
| Vifor Pharma, Inc. | $285.83 | 20 | $0 (2024) |
| Horizon Therapeutics plc | $238.71 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,070 | 59 | AstraZeneca Pharmaceuticals LP ($203.59) |
| 2023 | $1,413 | 75 | AstraZeneca Pharmaceuticals LP ($292.22) |
| 2022 | $1,283 | 73 | Aurinia Pharma U.S., Inc. ($188.17) |
| 2021 | $1,384 | 86 | Aurinia Pharma U.S., Inc. ($215.48) |
| 2020 | $408.85 | 28 | AstraZeneca Pharmaceuticals LP ($58.93) |
| 2019 | $533.79 | 40 | AstraZeneca Pharmaceuticals LP ($98.47) |
| 2018 | $730.67 | 46 | Otsuka America Pharmaceutical, Inc. ($128.74) |
| 2017 | $844.23 | 49 | Novartis Pharmaceuticals Corporation ($142.67) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Nephrology | ||||||
| 12/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/26/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Immunology | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.38 | General |
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: NEPHROLOGY | ||||||
| 10/21/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: NEPHROLOGY | ||||||
| 09/26/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Hyperkalemia | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Cardio-renal | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CRITICAL CARE | ||||||
| 09/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Nephrology | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.31 | General |
| 08/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 309 | 850 | $130,975 | $58,278 |
| 2022 | 9 | 446 | 979 | $142,200 | $64,891 |
| 2021 | 9 | 479 | 1,000 | $142,945 | $83,490 |
| 2020 | 9 | 448 | 916 | $131,120 | $62,390 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 684 | $119,700 | $52,297 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 45 | $9,075 | $4,807 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $640.00 | $525.92 | 82.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 16 | 16 | $640.00 | $350.40 | 54.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 64 | 89 | $920.00 | $297.45 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 697 | $121,975 | $54,029 | 44.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 28 | 28 | $7,270 | $5,024 | 69.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 26 | $5,260 | $2,343 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $2,775 | $1,340 | 48.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $1,180 | $877.23 | 74.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 27 | 27 | $1,080 | $569.43 | 52.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 18 | 29 | $1,450 | $309.45 | 21.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 72 | 82 | $820.00 | $282.16 | 34.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 27 | 39 | $390.00 | $115.83 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 681 | $119,175 | $69,222 | 58.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 32 | 32 | $8,300 | $5,708 | 68.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 31 | $6,200 | $4,454 | 71.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 30 | $3,750 | $1,830 | 48.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 34 | 34 | $1,360 | $698.02 | 51.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 36 | 36 | $1,460 | $659.05 | 45.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 20 | 28 | $1,400 | $492.00 | 35.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 73 | 89 | $910.00 | $309.72 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 28 | 39 | $390.00 | $117.00 | 30.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 190 | 626 | $109,100 | $51,579 | 47.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 20 | 20 | $4,640 | $3,072 | 66.2% |
About Dr. Alan Haratz, MD
Dr. Alan Haratz, MD is a Internal Medicine healthcare provider based in Eatontown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336155688.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Haratz, MD has received a total of $7,667 in payments from pharmaceutical and medical device companies, with $1,070 received in 2024. These payments were reported across 456 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,363).
As a Medicare-enrolled provider, Haratz has provided services to 1,682 Medicare beneficiaries, totaling 3,745 services with total Medicare billing of $269,049. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Eatontown, NJ
- Active Since 07/31/2006
- Last Updated 03/08/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1336155688
Products in Payments
- Kerendia (Drug) $759.00
- LUPKYNIS (Drug) $730.64
- FARXIGA (Drug) $583.35
- JYNARQUE (Drug) $469.80
- Veltassa (Drug) $421.60
- Velphoro (Drug) $302.36
- LOKELMA (Drug) $291.00
- KRYSTEXXA (Biological) $247.20
- RAYALDEE (Drug) $227.29
- ACTHAR (Biological) $211.91
- Edarbi (Drug) $205.01
- Rayaldee (Drug) $202.33
- NORTHERA (Drug) $173.40
- Auryxia (Drug) $157.24
- Tavneos (Drug) $153.63
- INJECTAFER (Drug) $144.47
- ENTRESTO (Drug) $142.67
- JESDUVROQ (Drug) $130.31
- GATTEX (Drug) $104.24
- Parsabiv (Drug) $100.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Eatontown
Dr. Matthew Saybolt, M.d, M.D
Internal Medicine — Payments: $139,302
Dr. Pratik Panchal, M.d, M.D
Internal Medicine — Payments: $28,683
Dr. Manar Hanna, Md, MD
Internal Medicine — Payments: $26,115
David Anwar, Do, DO
Internal Medicine — Payments: $19,233
Dr. Marielle Recho, M.d, M.D
Internal Medicine — Payments: $16,595
Dr. Julie Master, D.o, D.O
Internal Medicine — Payments: $13,467